ResMed (RMD)

R&D Expenses

$378.28M

TTM · Period ending: · USD

RMD logo

RMD R&D Expenses

Latest reported$378.28M
RMD TTM R&D Expenses ($0.00 → $378.28M)
High-resolution chart · PNG

RMD r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ResMed R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
11,146,000
10,446,000
9,532,000
9,027,000
8,538,000
7,903,000
7,300,000
6,900,000
6,400,000
5,700,000
5,500,000
5,100,000
5,000,000
4,900,000
4,700,000
4,400,000
3,900,000
3,600,000
3,100,000
2,200,000
1,400,000
600,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.